Literature DB >> 12523502

Apoptosis in myocardial infarction.

Manuel Rodríguez1, Benedict R Lucchesi, Jutta Schaper.   

Abstract

Apoptosis, one of the major forms of cell death, has been implicated in different cardiovascular diseases. In this paper we review many of the different studies that have been performed to address the occurrence of apoptotic cell death associated with myocardial infarction. A definitive differentiation between apoptosis and other forms of cell death is still needed, mainly because of differences and limitations of the methods used for detection. In myocardial infarction apoptosis has been reported at acute stages of evolution in the ischemic area as well as in remote zones. In the ischemic area it might be a determinant of the final size of the infarct and it seems to depend on the presence of post-ischemic reperfusion. However, the incidence of apoptosis reported until now varies widely. In the myocardium remote from the ischemic area it might be associated with the progression towards heart failure. At present, the role and significance of apoptosis in myocardial infarction is rather inconclusive. Further studies are needed to solve methodological uncertainties and clarify the mechanisms involved in the process of cell death, which is particularly important as a basis for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12523502     DOI: 10.1080/078538902321012414

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  22 in total

1.  MicroRNA-322 protects hypoxia-induced apoptosis in cardiomyocytes via BDNF gene.

Authors:  Liguo Yang; Shigang Song; Hang Lv
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction.

Authors:  Kerstin Schwarz; Gregor Simonis; Xinjian Yu; Stephan Wiedemann; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

Authors:  Luis Cardoso; Brad C Herman; Olivier Verborgt; Damien Laudier; Robert J Majeska; Mitchell B Schaffler
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

4.  Maternal high-salt intake during pregnancy reprogrammed renin-angiotensin system-mediated cardiomyocyte apoptosis in the adult offspring heart.

Authors:  Juanxiu Lv; Peiwen Zhang; Yujuan Zhang; Hanzhe Kuang; Li Cao; Conglong Wu; Lin Jiang; Dawei Li; Caiping Mao; Zhice Xu
Journal:  Reprod Sci       Date:  2013-05-20       Impact factor: 3.060

5.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

6.  Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling.

Authors:  Dazhong Xu; Richard D Patten; Thomas Force; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  MicroRNA: A matter of life or death.

Authors:  Zhiguo Wang
Journal:  World J Biol Chem       Date:  2010-04-26

8.  Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage.

Authors:  B C Herman; L Cardoso; R J Majeska; K J Jepsen; M B Schaffler
Journal:  Bone       Date:  2010-07-12       Impact factor: 4.398

9.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

Review 10.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.